跳至主要内容
临床试验/NCT02544776
NCT02544776已完成不适用

Effect of Amlodipine and Clomid on Blood Flow of Preovulatory Follicle in Polycystic Ovarian Patients

Ahmed Fathy Ali Mohamed Ghanem0 个研究点目标入组 60 人开始时间: 2015年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
主要终点
change in ovarian artery perfusion

研究概览

简要总结

On the basis of the current study, amlodipine seems to be a promising drug on improving uterine, ovarian blood flow, size of pre-ovulatory follicle, midluteal progesterone level and pregnancy outcome in patients with pco.

详细描述

To know if amlodipine has vasodilator effect on ovarian ar. In pco patient.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
20 Years 至 35 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Demographic features including females in age of ≥20 & ≤35, and BMI of ≤
  • Infertility secondary to polycystic ovary , The choice of polycystic ovary patients will be according to the Rotterdam consensus workshop (Rotterdam, 2004), and the diagnosis of polycystic ovary by ultrasonography will be made according to Adams et al. criteria which are the most often cited (Adams et al., 1985).The Rotterdam criteria as follows:
  • Oligo- or anovulation.
  • Clinical and/or biochemical signs of hyper androgynism
  • The presence of polycystic ovaries on ultrasound scan. Ultrasound findings of enlarged ovaries with multiple small cysts (10-12 or more of 2-9 mm in diameter) scattered around the periphery and highly echogenic stroma

排除标准

  • Including other causes of infertility diagnosed during infertility work up.
  • Patients refused to participate or to continue study.
  • Also, hepatic, cardiac, and hypotensive patients will be excluded from the study.

研究组 & 干预措施

Clomifene citrate and Amlodipine

Experimental

Amlodipine 5mg tablet and Clomifene citrate 50 mg tablet once by mouth daily at morning starting from day number 5 of menstrual cycle till day number 9.

干预措施: Clomifene citrate ( clomid 50 mg ) (Drug)

Clomifene citrate and Amlodipine

Experimental

Amlodipine 5mg tablet and Clomifene citrate 50 mg tablet once by mouth daily at morning starting from day number 5 of menstrual cycle till day number 9.

干预措施: Amlodipine (Drug)

Clomifene citrate

Active Comparator

Clomifene citrate 50mg and once daily at morning starting from day number 5 of menstrual cycle till day number 9

干预措施: Clomifene citrate ( clomid 50 mg ) (Drug)

结局指标

主要结局

change in ovarian artery perfusion

时间窗: day number five and day number 9 of menstrual cycle

peak systolic velocity ( psv ) measured by doppler u/s

次要结局

  • Number of mature follicle(day 14 of menstrual cycle)
  • endometrial thickening(day number five and day number 9 of menstrual cycle)

研究者

发起方
Ahmed Fathy Ali Mohamed Ghanem
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Ahmed Fathy Ali Mohamed Ghanem

Resident of Obstetrics and Gynecology

Ain Shams Maternity Hospital

相似试验